MA10-MA50 Bull Crossover: Fidelity National Financial (FNF), Juno Therapeutics Inc.(JUNO)

NYSE: FNF (Fidelity National Financial)

FNF Group will release 2nd quarter 2015 earnings after the close of regular market trading on Wednesday, July 29, 2015.  A conference call will follow at 11:00 a.m. Eastern Time on Thursday, July 30, 2015.

FNF has closed at $38.14, its traded Volume was 1330.72K shares, FNF opened the Day at $37.61, it made an intraday Low of $37.2, and an intraday High of $38.14. FNF (Fidelity National Financial) 52-week High is $38.928, 52-week Low is: $25.238, it has supports at $36.75 and $35.41, resistances at $38.92 and $45.45. FNF’s earning is $2.42 per share, Next quarter estimated EPS is $0, current year estimated EPS is $3.32. Its PE ratio is 16. Overall, this stock is rated BUY today.

NASDAQ: JUNO (Juno Therapeutics Inc.)

Juno Therapeutics’ deal last week with New Jersey biopharmaceutical company Celgene Corp. (Nasdaq: CELG) caused Juno’s stock to explode. The deal means Celgene will pay Juno $1 billion including the purchase of about 9.1 million shares of Juno stock at $93 per share.

JUNO has closed at $54.33, its traded Volume was 2462.13K shares, JUNO opened the Day at $53.52, it made an intraday Low of $53.05, and an intraday High of $55.33. JUNO (Juno Therapeutics Inc.) 52-week High is $69.28, 52-week Low is: $38, it has supports at $40.59 and $33.77, resistances at $58.31 and $69.27. JUNO’s earning is $-13.35 per share, Next quarter estimated EPS is $0, current year estimated EPS is $-1.5. Its PE ratio is -4. Overall, this stock is rated BUY today.